Sign in
4

Changes in Ownership

CRESCENT BIOPHARMA, INC. Filed Acc 0001415889-24-017978

Chief Medical Officer bought 305,000 shares at an average $0.26 ($78,825)

From the SEC's structured data for this filing

Trades in this filing

Rock Edwin · Chief Medical Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-06-20 Purchase : show line 1 in the form +190,000 $0.25 $48,108 565,403 D
2024-06-21 Purchase : show line 2 in the form +115,000 $0.27 $30,717 680,403 D
Open-market purchases · 305,000 sh · avg $0.26 · $78,825
Loading xslF345X05/form4-06242024_080643.xml…